ResMed today introduced Mobi, its first ResMed-branded portable oxygen concentrator (POC). An image of the product is not available at this time.
Mobi offers an industry-leading balance of oxygen delivery, weight and battery life so that millions with chronic obstructive pulmonary disease (COPD) or other respiratory condition can enjoy ResMed-quality oxygen therapy at home or on the go.
“We have focused decades of patient-centered ResMed technology and design innovation into this POC,” said ResMed CEO Mick Farrell. “We’ve achieved great mobility, comfort and therapy quality in sleep apnea treatment with AirMini, the world’s smallest PAP device. Mobi offers that same great balance to the many millions of people who rely on supplemental oxygen to enjoy their highest quality of life.”
Mobility is particularly key for oxygen patients with chronic obstructive pulmonary disease. Regular physical activity is shown to lower the risk of hospitalization and death among those with COPD, according to a 2006 study published in Thorax.
“The time is now for portable oxygen,” said Farrell. “Our patients demand a device that enables them to get out of their house and travel to visit friends and family. Mobi gives the gift of freedom to millions.”
Mobi will be available to U.S. patients through their home medical equipment (HME) providers later this quarter. ResMed is pursuing clearance to sell in other countries in 2018.